News Archive

 

Whitehead’s Susan Lindquist elected to UK’s Royal Society

May 1, 2015

The UK’s Royal Society today announced that it has elected Whitehead Institute’s Susan Lindquist as a Foreign Member.

Whitehead Founding Member Rudolf Jaenisch

Whitehead’s Rudolf Jaenisch honored with March of Dimes Prize

April 27, 2015

The prize honors Jaenisch’s groundbreaking body of work in epigenetics, the development of transgenic animals, and the generation and use of induced pluripotent stem (iPS) cells.

Image showing tumors

Imaging immunity: Noninvasive imaging of immune system detects tumors, could monitor therapeutic response

April 20, 2015

A novel approach that allows real-time imaging of the immune system’s response to the presence of tumors—without the need for blood draws or invasive biopsies—offers a potential breakthrough both in diagnostics and in the ability to monitor efficacy of cancer therapies.

Whitehead Member Jing-Ke Weng

Whitehead Member Jing-Ke Weng named a Searle Scholar

April 14, 2015

Whitehead Institute Member Jing-Ke Weng is among 15 young scientists nationwide to be named a 2015 Searle Scholar.

Image of brain samples showing gene activity in ischemic areas

Biologists identify brain tumor weakness

April 8, 2015

Biologists at Whitehead Institute and MIT have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors.

Image of red and white yeast colonies

CRISPR-Cas genome editing of Candida albicans holds promise for overcoming deadly fungal infections

April 3, 2015

Candida albicans is a human pathogen that causes potentially lethal infections in immunocompromised individuals. Efforts to overcome Candida’s innate resistance to many drugs have been thwarted by an absence of tools enabling genetic modifications. Now, using a modified CRISPR-Cas system, Whitehead Institute researchers can edit the fungus’s genome systematically—an approach that could help scientists understand Candida’s unique biology and identify potential drug targets.

Dividing human mammary stem cells

Age discrimination during cell division maintains the ‘stem’ in stem cells

April 2, 2015

A team of Whitehead Institute scientists has discovered that during division, stem cells distinguish between old and young mitochondria and allocate them disproportionately between daughter cells.

Diagram of how Scr7 improves CRISPR/Cas

Refined CRISPR/Cas genome editing accelerates generation of transgenic mice

March 23, 2015

Although the genome editing system known as CRISPR/Cas has revolutionized genetic research in cell lines, its overall efficiency has been relatively poor when used to generate genetically altered animals for disease modeling.  Now Whitehead Institute scientists have altered the approach in a manner that could accelerate the production of mice carrying precise mutations of multiple genes.

Transmembrane protein SLC38A9 appears to act as a nutrients sensor for the mTORC1 metabolic pathway

Scientists identify first nutrient sensor in key growth-regulating metabolic pathway

January 7, 2015

Scientists in the lab of Whitehead Institute Member David Sabatini have for the first time identified a protein that appears to be a nutrient sensor for the key growth-regulating mTORC1 metabolic pathway. 

Family of neural-associated RNA-binding proteins found to regulate cell state in breast cancer

December 15, 2014

A widely conserved family of RNA-binding proteins known to be expressed in neural stem cells and other stem cell types has now been shown to play a role in controlling both the state and behavior of breast cancer cells.

Heat-shock protein enables tumor evolution and drug resistance in breast cancer

December 8, 2014

Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 (HSP90) also enables estrogen receptor-positive (ER+) breast cancers to develop resistance to hormonal therapy.  

Schematic depicting creation of stable induced neural stem cells (iNSCs)

Direct generation of neural stem cells could enable transplantation therapy

November 6, 2014

Induced neural stem cells (iNSCs) hold promise for therapeutic transplantation, but their potential in this capacity has been limited by failed efforts to maintain such cells in their multi-potent NSC state. Now, Whitehead Institute scientists have created iNSCs that remain in the multi-potent state—without ongoing expression of reprogramming factors. This allows the iNSCs to self-renew repeatedly to generate cells in quantities sufficient for therapy.

Pages

© Whitehead Institute for Biomedical Research         Nine Cambridge Center    Cambridge, MA 02142